Bioinformatics analysis of biomarkers and transcriptional factor motifs in Down syndrome

In this study, biomarkers and transcriptional factor motifs were identified in order to investigate the etiology and phenotypic severity of Down syndrome. GSE 1281, GSE 1611, and GSE 5390 were downloaded from the gene expression ominibus (GEO). A robust multiarray analysis (RMA) algorithm was applied to detect differentially expressed genes (DEGs). In order to screen for biological pathways and to interrogate the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database, the database for annotation, visualization, and integrated discovery (DAVID) was used to carry out a gene ontology (GO) function enrichment for DEGs. Finally, a transcriptional regulatory network was constructed, and a hypergeometric distribution test was applied to select for significantly enriched transcriptional factor motifs. CBR1, DYRK1A, HMGN1, ITSN1, RCAN1, SON, TMEM50B, and TTC3 were each up-regulated two-fold in Down syndrome samples compared to normal samples; of these, SON and TTC3 were newly reported. CBR1, DYRK1A, HMGN1, ITSN1, RCAN1, SON, TMEM50B, and TTC3 were located on human chromosome 21 (mouse chromosome 16). The DEGs were significantly enriched in macromolecular complex subunit organization and focal adhesion pathways. Eleven significantly enriched transcription factor motifs (PAX5, EGR1, XBP1, SREBP1, OLF1, MZF1, NFY, NFKAPPAB, MYCMAX, NFE2, and RP58) were identified. The DEGs and transcription factor motifs identified in our study provide biomarkers for the understanding of Down syndrome pathogenesis and progression.

[1]  Xiang-Dong Fu,et al.  SON controls cell-cycle progression by coordinated regulation of RNA splicing. , 2011, Molecular cell.

[2]  M. Dierssen,et al.  NGF Upregulates the Plasminogen Activation Inhibitor-1 in Neurons via the Calcineurin/NFAT Pathway and the Down Syndrome-Related Proteins DYRK1A and RCAN1 Attenuate This Effect , 2013, PloS one.

[3]  X. Estivill,et al.  DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. , 2000, Human molecular genetics.

[4]  David J. Arenillas,et al.  JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles , 2009, Nucleic Acids Res..

[5]  L. Buluwela,et al.  Organization and conservation of the GART/SON/DONSON locus in mouse and human genomes. , 2000, Genomics.

[6]  E. Graaff,et al.  Enteric Nervous System Progenitors Are Coordinately Controlled by the G Protein-Coupled Receptor EDNRB and the Receptor Tyrosine Kinase RET , 2003, Neuron.

[7]  M. Arbonés,et al.  Upregulation of RCAN1 causes Down syndrome-like immune dysfunction , 2013, Journal of Medical Genetics.

[8]  Trey Ideker,et al.  An Integrated Systems Analysis Implicates EGR1 Downregulation in Simian Immunodeficiency Virus Encephalitis-Induced Neural Dysfunction , 2009, The Journal of Neuroscience.

[9]  Jing Li,et al.  CASCADE_SCAN: mining signal transduction network from high-throughput data based on steepest descent method , 2011, BMC Bioinformatics.

[10]  P. Pandolfi,et al.  Mzf1 controls cell proliferation and tumorigenesis. , 2001, Genes & development.

[11]  Stylianos E. Antonarakis,et al.  Chromosome 21 and Down syndrome: from genomics to pathophysiology , 2004, Nature Reviews Genetics.

[12]  Y. Hérault,et al.  Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans. , 2014, Molecular nutrition & food research.

[13]  M. Pritchard,et al.  Alzheimer's disease and endocytic dysfunction: Clues from the Down syndrome-related proteins, DSCR1 and ITSN1 , 2006, Ageing Research Reviews.

[14]  A. Visel,et al.  Transmembrane protein 50b (C21orf4), a candidate for Down syndrome neurophenotypes, encodes an intracellular membrane protein expressed in the rodent brain , 2008, Neuroscience.

[15]  Christie S. Chang,et al.  The BioGRID interaction database: 2013 update , 2012, Nucleic Acids Res..

[16]  C. Fletcher,et al.  Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Zengrong Liu,et al.  System approaches reveal the molecular networks involved in neural stem cell differentiation , 2012, Protein & Cell.

[18]  Eun-Ah Christine Song,et al.  Dyrk1A-mediated phosphorylation of RCAN1 promotes the formation of insoluble RCAN1 aggregates , 2013, Neuroscience Letters.

[19]  O. Ward.  John Langdon Down: the man and the message. , 1999, Down's syndrome, research and practice : the journal of the Sarah Duffen Centre.

[20]  M. Weiss.  Conditional Love: Parents' Attitudes Toward Handicapped Children , 1994 .

[21]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[22]  W. Thies,et al.  2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.

[23]  L. Personnaz,et al.  The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome. , 2005, Human molecular genetics.

[24]  Anna M. Lee,et al.  Prkcz null mice show normal learning and memory , 2012, Nature.

[25]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[26]  N. Hastie,et al.  Transcriptome analysis of human autosomal trisomy. , 2002, Human molecular genetics.

[27]  Dustin E. Schones,et al.  The Chromatin-binding Protein HMGN1 Regulates the Expression of Methyl CpG-binding Protein 2 (MECP2) and Affects the Behavior of Mice* , 2011, The Journal of Biological Chemistry.

[28]  Mary Goldman,et al.  The UCSC Genome Browser database: update 2011 , 2010, Nucleic Acids Res..

[29]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[30]  A. Holland,et al.  Gene expression profiling in the adult Down syndrome brain. , 2007, Genomics.

[31]  Debashis Sahoo,et al.  MiDReG: A method of mining developmentally regulated genes using Boolean implications , 2010, Proceedings of the National Academy of Sciences.

[32]  Eduardo D. Martín,et al.  Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome , 2013, Neurobiology of Disease.

[33]  B. Johansson,et al.  High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome , 2012, Genes, chromosomes & cancer.

[34]  Jennifer M. Rust,et al.  The BioGRID Interaction Database , 2011 .

[35]  E. Domany,et al.  Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. , 2010, Blood.

[36]  Terrence S. Furey,et al.  The UCSC Genome Browser Database: update 2006 , 2005, Nucleic Acids Res..

[37]  L. Tsai,et al.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration , 1999, Nature.

[38]  K. Yamakawa,et al.  Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. , 2004, Human molecular genetics.

[39]  Kara Dolinski,et al.  The BioGRID Interaction Database: 2011 update , 2010, Nucleic Acids Res..

[40]  M. Fekkes,et al.  Problem behavior of individuals with Down syndrome in a nationwide cohort assessed in late adolescence. , 2013, The Journal of pediatrics.

[41]  Alzheimer’s Association,et al.  2011 Alzheimer’s disease facts and figures , 2011, Alzheimer's & Dementia.

[42]  Fei He,et al.  Different effects of the probe summarization algorithms PLIER and RMA on high-level analysis of Affymetrix exon arrays , 2010, BMC Bioinformatics.

[43]  Svend Juul,et al.  Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. , 2006, The Journal of clinical endocrinology and metabolism.

[44]  Michael Bustin,et al.  Chromosomal protein HMGN1 enhances the rate of DNA repair in chromatin , 2003, The EMBO journal.

[45]  E. Courchesne,et al.  Protocols to establish genotype-phenotype correlations in Down syndrome. , 1991, American journal of human genetics.